MENU

Program Committee

To download the Program Committee brochure here.


  • Shaifali Bhalla, Ph.D.

    Dr. Shaifali Bhalla is Associate Professor of Pharmaceutical Sciences and Associate Dean of Administrative Affairs at Midwestern University College of Pharmacy, Downers Grove, IL. She received her Ph.D. from the University of Illinois at Chicago, USA in 2005. Dr. Bhalla's ...

    See more See less
  • Matthew Flegal

    Matt entered the research field over 20 years ago as a lab animal technician at the TSI/Mason contract research facility. He has worked at both contract facilities such as TSI and OREAD Biosafety as well in industry at Pharmacia, Pfizer, and Sanofi-Aventis. During that period he ...

    See more See less
  • Professor Kevin Pfleger, MA, PhD, FBPhS

    Professor Pfleger is Director, Biomedical Innovation at The University of Western Australia (UWA) and the MTPConnect Western Australian Life Sciences Innovation Hub. He is also Head of Molecular Endocrinology and Pharmacology at the UWA Centre for Medical Research and Harry ...

    See more See less
  • Martin Shaw

    Between 1994-2015 he worked at EKF Diagnostics in Wales (formerly Argutus Medical) where he introduced and promoted a wide range of novel kidney and liver tests, including important biomarkers that are now being evaluated by the IMI (Innovative Medicines Initiative) and FDA as ...

    See more See less
  • Matthew Shipton

    Over the past 16 years, Mr. Shipton has amassed deep domain expertise in cell-based products and services. Currently serving as President of Novabiosis, Inc. Mr. Shipton brings a skill for implementing sales-driven business strategies, an extensive track record of meeting and ...

    See more See less
FEB 23, 2022

Drug Discovery & Development Virtual Event Series 2022



Labroots and the Drug Discovery planning committee are pleased to announce the 5th annual event in the Drug Discovery & Development Virtual Event Series. Labroots will host this online-only event on February 23, 2022. The Drug Discovery planning committee will invite speakers from industry and academia to discuss key challenges, new opportunities, and recent successes in the current landscape of drug discovery and development.

The tracks include:
  • Novel Approaches to Drug Discovery and Preclinical Development
    • Emerging Assays
    • Patient-derived Organoid Models
    • Systems to Predict Safety and Efficacy
  • Explorations into PK/PD and Pharmacogenomics
    • PGX of GPCRs
    • In-vitro Models of Toxicity
  • Advancements in Clinical Development
    • Health Equality and Genetic Diversity in Clinical Trials
    • Innovations in Biomarkers
    • Digital Solutions
    • Proteomics

Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Plan now to have your poster included in the 2022 Drug Discovery & Development Virtual Event. Submission is free. Submit your abstract here.

Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open for 2 years from the date of the live event, and the webinars will be available for unlimited on-demand viewing.  This virtual conference also offers increased reach for the global drug discovery community with a high degree of interaction through live-streaming video and chat sessions.

Continuing Education
Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 30 credits.

Labroots is a proud partner of Chati, a virtual event platform that allows for the hosting of engaging and interactive virtual and hybrid events, catering to businesses of any vertical or size.

Use #LRdrug to follow the conversation!


Speakers
  • Esperanza Anguiano, PhD, MS-MBA

    Scientific Market Development Director of BioPharma, Nanostring
    BIOGRAPHY
  • Hilal Arnouk, MD, PhD

    Associate Professor, Dept. of Pathology, Midwestern University
    BIOGRAPHY
  • Emily Bozek, MSc

    Product Manager
    BIOGRAPHY
  • Audrey Dubourg, MSc, PhD

    Product Manager OOC, CN-Bio
    BIOGRAPHY
  • Fergus Fleming

    Co-Founder, Executive Director, Chief Technical Officer, Renalytix PLC
    BIOGRAPHY
  • Christina Gonzalez

    Project Manager, Pathology, ICON
    BIOGRAPHY
  • Alexander Sebastian Hauser, PhD

    Assistant Professor, Department of Drug Design and Pharmacology, University of Copenhagen
    BIOGRAPHY
  • Michael Johnson, PhD

    CEO and Co-Founder, Visikol
    BIOGRAPHY
  • Ines Liebscher, PhD

    Professor, Leipzig University, Rudolf-Schönheimer-Institute of Biochemistry
    BIOGRAPHY
  • Michelle Longmire, MD

    CEO & Co-founder, Medable
    BIOGRAPHY
  • Debbie Marshall

    Program Manager, ICON
    BIOGRAPHY
  • Paul McCracken, PhD

    Vice President, Global Head of Medical Imaging, ICON
    BIOGRAPHY
  • James McKim, PhD

    President and CEO, IONTOX
    BIOGRAPHY
  • Joseph Pearson, PhD

    Global Product Manger, QIAGEN Digital Insights
    BIOGRAPHY
  • Professor Kevin Pfleger, MA, PhD, FBPhS

    Director, Biomedical and Health Innovation, The University of Western Australia and WA Life Sciences Innovation Hub; President, Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT); Head, Molecular Endocrinology and Pharmacology, Harry Perkins Institute of Medical Research (Centre for Medical Research, The University of Western Australia); Deputy Director & UWA Node Leader, ARC Centre for Personalised Therapeutics Technologies
    BIOGRAPHY
  • Nikolina Radulovich, PhD

    Staff Scientist, Princess Margaret Hospital in Toronto
    BIOGRAPHY
  • Stacey Ward, PhD

    R&D Manager, Advanced Genetic and Cell Technologies, MilliporeSigma
    BIOGRAPHY
  • Hans-Dieter Zucht, PhD

    Chief Technical Officer, Oncimmune Germany GmbH
    BIOGRAPHY

You May Also Like

Agenda

  • FEB 23, 2022 6:00 AM PST

    Autoantibodies as Biomarkers in Immuno-oncology

    Hans-Dieter Zucht, PhD
    Chief Technical Officer, Oncimmune Germany GmbH
    BIOGRAPHY
  • FEB 23, 2022 7:30 AM PST

    Keynote Presentation: Profiling of Receptor Complexes using BRET

    Professor Kevin Pfleger, MA, PhD, FBPhS
    Director, Biomedical and Health Innovation, The University of Western Australia and WA Life Sciences Innovation Hub; President, Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT); Head, Molecular Endocrinology and Pharmacology, Harry Perkins Institute of Medical Research (Centre for Medical Research, The University of Western Australia); Deputy Director & UWA Node Leader, ARC Centre for Personalised Therapeutics Technologies
    BIOGRAPHY
  • FEB 23, 2022 9:00 AM PST

    Keynote Presentation: Engineering the Quantum Leap that Drug Development Needs

    Michelle Longmire, MD
    CEO & Co-founder, Medable
    BIOGRAPHY
  • FEB 23, 2022 10:30 AM PST

    Standardized and Reproducible Solutions for Flow Cytometry Analytics

    Emily Bozek, MSc
    Product Manager
    BIOGRAPHY
    Sponsored By: Miltenyi Biotec
  • FEB 23, 2022 12:00 PM PST

    Panel Presentation: Digital Solutions to Alleviate NASH Clinical Trial Challenges

    Paul McCracken, PhD
    Vice President, Global Head of Medical Imaging, ICON
    Debbie Marshall
    Program Manager, ICON
    Christina Gonzalez
    Project Manager, Pathology, ICON
  • FEB 23, 2022 1:30 PM PST

    Human-Certified 'omics Data to Power Drug Discovery

    Joseph Pearson, PhD
    Global Product Manger, QIAGEN Digital Insights
    BIOGRAPHY
    Sponsored By: QIAGEN
  • FEB 23, 2022 1:30 PM PST

    Innovative Approaches to Biomarker Discovery in the Drug Development Process

    Esperanza Anguiano, PhD, MS-MBA
    Scientific Market Development Director of BioPharma, Nanostring
    BIOGRAPHY
    Sponsored By: NanoString Technologies
  • FEB 23, 2022 3:00 PM PST

    Genetically Engineered Custom Cell Lines for Pre-Clinical Research and Biomanufacturing

    Stacey Ward, PhD
    R&D Manager, Advanced Genetic and Cell Technologies, MilliporeSigma
    BIOGRAPHY
    Sponsored By: MilliporeSigma
  • Addressing Both Sides of the Coin - Microphysiological Systems to Better Predict Safety and Efficacy of Novel Therapies

    Audrey Dubourg, MSc, PhD
    Product Manager OOC, CN-Bio
    BIOGRAPHY
  • Development and Characterization of an In Vitro Integrated Organ Platform for the Evaluation of Pharmacokinetic and Toxicologic Effects of Drugs and Chemicals

    James McKim, PhD
    President and CEO, IONTOX
    BIOGRAPHY
  • Enabling Translation of Biomarker Research to Clinical Practice

    Fergus Fleming
    Co-Founder, Executive Director, Chief Technical Officer, Renalytix PLC
    BIOGRAPHY
  • How to Wake a Giant - Concepts of Adhesion GPCR Activation and their Potential Therapeutic Implications

    Ines Liebscher, PhD
    Professor, Leipzig University, Rudolf-Schönheimer-Institute of Biochemistry
    BIOGRAPHY
  • Identification of Novel Protein Biomarkers in the Era of Precision Medicine Oncology

    Hilal Arnouk, MD, PhD
    Associate Professor, Dept. of Pathology, Midwestern University
    BIOGRAPHY
  • Identifying the Ideal In Vitro Liver Model for Various Research Applications

    Michael Johnson, PhD
    CEO and Co-Founder, Visikol
    BIOGRAPHY
  • Next Generation Biobanking of Patient-derived Organoid Models

    Nikolina Radulovich, PhD
    Staff Scientist, Princess Margaret Hospital in Toronto
    BIOGRAPHY
  • Personalised Medicine Through GPCR Pharmacogenomics

    Alexander Sebastian Hauser, PhD
    Assistant Professor, Department of Drug Design and Pharmacology, University of Copenhagen
    BIOGRAPHY
  • Advancements in Clinical Development
  • FEB 23, 2022 6:00 AM PST

    Autoantibodies as Biomarkers in Immuno-oncology

    Hans-Dieter Zucht, PhD
    Chief Technical Officer, Oncimmune Germany GmbH
    BIOGRAPHY
  • FEB 23, 2022 9:00 AM PST

    Keynote Presentation: Engineering the Quantum Leap that Drug Development Needs

    Michelle Longmire, MD
    CEO & Co-founder, Medable
    BIOGRAPHY
  • FEB 23, 2022 12:00 PM PST

    Panel Presentation: Digital Solutions to Alleviate NASH Clinical Trial Challenges

    Paul McCracken, PhD
    Vice President, Global Head of Medical Imaging, ICON
    Debbie Marshall
    Program Manager, ICON
    Christina Gonzalez
    Project Manager, Pathology, ICON
  • FEB 23, 2022 1:30 PM PST

    Innovative Approaches to Biomarker Discovery in the Drug Development Process

    Esperanza Anguiano, PhD, MS-MBA
    Scientific Market Development Director of BioPharma, Nanostring
    BIOGRAPHY
    Sponsored By: NanoString Technologies
  • Identification of Novel Protein Biomarkers in the Era of Precision Medicine Oncology

    Hilal Arnouk, MD, PhD
    Associate Professor, Dept. of Pathology, Midwestern University
    BIOGRAPHY
  • Enabling Translation of Biomarker Research to Clinical Practice

    Fergus Fleming
    Co-Founder, Executive Director, Chief Technical Officer, Renalytix PLC
    BIOGRAPHY
  • Novel Approaches to Drug Discovery and Preclinical Development
  • FEB 23, 2022 7:30 AM PST

    Keynote Presentation: Profiling of Receptor Complexes using BRET

    Professor Kevin Pfleger, MA, PhD, FBPhS
    Director, Biomedical and Health Innovation, The University of Western Australia and WA Life Sciences Innovation Hub; President, Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT); Head, Molecular Endocrinology and Pharmacology, Harry Perkins Institute of Medical Research (Centre for Medical Research, The University of Western Australia); Deputy Director & UWA Node Leader, ARC Centre for Personalised Therapeutics Technologies
    BIOGRAPHY
  • FEB 23, 2022 10:30 AM PST

    Standardized and Reproducible Solutions for Flow Cytometry Analytics

    Emily Bozek, MSc
    Product Manager
    BIOGRAPHY
    Sponsored By: Miltenyi Biotec
  • FEB 23, 2022 1:30 PM PST

    Human-Certified 'omics Data to Power Drug Discovery

    Joseph Pearson, PhD
    Global Product Manger, QIAGEN Digital Insights
    BIOGRAPHY
    Sponsored By: QIAGEN
  • FEB 23, 2022 3:00 PM PST

    Genetically Engineered Custom Cell Lines for Pre-Clinical Research and Biomanufacturing

    Stacey Ward, PhD
    R&D Manager, Advanced Genetic and Cell Technologies, MilliporeSigma
    BIOGRAPHY
    Sponsored By: MilliporeSigma
  • How to Wake a Giant - Concepts of Adhesion GPCR Activation and their Potential Therapeutic Implications

    Ines Liebscher, PhD
    Professor, Leipzig University, Rudolf-Schönheimer-Institute of Biochemistry
    BIOGRAPHY
  • Next Generation Biobanking of Patient-derived Organoid Models

    Nikolina Radulovich, PhD
    Staff Scientist, Princess Margaret Hospital in Toronto
    BIOGRAPHY
  • Identifying the Ideal In Vitro Liver Model for Various Research Applications

    Michael Johnson, PhD
    CEO and Co-Founder, Visikol
    BIOGRAPHY
  • Addressing Both Sides of the Coin - Microphysiological Systems to Better Predict Safety and Efficacy of Novel Therapies

    Audrey Dubourg, MSc, PhD
    Product Manager OOC, CN-Bio
    BIOGRAPHY
  • Explorations into PK/PD and Pharmacogenomics
  • Personalised Medicine Through GPCR Pharmacogenomics

    Alexander Sebastian Hauser, PhD
    Assistant Professor, Department of Drug Design and Pharmacology, University of Copenhagen
    BIOGRAPHY
  • Development and Characterization of an In Vitro Integrated Organ Platform for the Evaluation of Pharmacokinetic and Toxicologic Effects of Drugs and Chemicals

    James McKim, PhD
    President and CEO, IONTOX
    BIOGRAPHY

Speakers


  • Esperanza Anguiano, PhD, MS-MBA

    Esperanza Anguiano, PhD, MS-MBA

    Scientific Market Development Director of BioPharma, Nanostring

    BIOGRAPHY
  • Hilal Arnouk, MD, PhD

    Hilal Arnouk, MD, PhD

    Associate Professor, Dept. of Pathology, Midwestern University

    BIOGRAPHY
  • Emily Bozek, MSc

    Emily Bozek, MSc

    Product Manager

    BIOGRAPHY
  • Audrey Dubourg, MSc, PhD

    Audrey Dubourg, MSc, PhD

    Product Manager OOC, CN-Bio

    BIOGRAPHY
  • Fergus Fleming

    Fergus Fleming

    Co-Founder, Executive Director, Chief Technical Officer, Renalytix PLC

    BIOGRAPHY
  • Christina Gonzalez

    Christina Gonzalez

    Project Manager, Pathology, ICON

    BIOGRAPHY
  • Alexander Sebastian Hauser, PhD

    Alexander Sebastian Hauser, PhD

    Assistant Professor, Department of Drug Design and Pharmacology, University of Copenhagen

    BIOGRAPHY
  • Michael Johnson, PhD

    Michael Johnson, PhD

    CEO and Co-Founder, Visikol

    BIOGRAPHY
  • Ines Liebscher, PhD

    Ines Liebscher, PhD

    Professor, Leipzig University, Rudolf-Schönheimer-Institute of Biochemistry

    BIOGRAPHY
  • Michelle Longmire, MD

    Michelle Longmire, MD

    CEO & Co-founder, Medable

    BIOGRAPHY
  • Debbie Marshall

    Debbie Marshall

    Program Manager, ICON

    BIOGRAPHY
  • Paul McCracken, PhD

    Paul McCracken, PhD

    Vice President, Global Head of Medical Imaging, ICON

    BIOGRAPHY
  • James McKim, PhD

    James McKim, PhD

    President and CEO, IONTOX

    BIOGRAPHY
  • Joseph Pearson, PhD

    Joseph Pearson, PhD

    Global Product Manger, QIAGEN Digital Insights

    BIOGRAPHY
  • Professor Kevin Pfleger, MA, PhD, FBPhS

    Professor Kevin Pfleger, MA, PhD, FBPhS

    Director, Biomedical and Health Innovation, The University of Western Australia and WA Life Sciences Innovation Hub; President, Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT); Head, Molecular Endocrinology and Pharmacology, Harry Perkins Institute of Medical Research (Centre for Medical Research, The University of Western Australia); Deputy Director & UWA Node Leader, ARC Centre for Personalised Therapeutics Technologies

    BIOGRAPHY
  • Nikolina Radulovich, PhD

    Nikolina Radulovich, PhD

    Staff Scientist, Princess Margaret Hospital in Toronto

    BIOGRAPHY
  • Stacey Ward, PhD

    Stacey Ward, PhD

    R&D Manager, Advanced Genetic and Cell Technologies, MilliporeSigma

    BIOGRAPHY
  • Hans-Dieter Zucht, PhD

    Hans-Dieter Zucht, PhD

    Chief Technical Officer, Oncimmune Germany GmbH

    BIOGRAPHY

Sponsors & Partners

For information on becoming a sponsor or exhibitor, please click here.


Event Series


Drug Discovery & Development Virtual Event Series 2025
February 19, 2025 6:00 am Pacific Time

Drug Discovery & Development Virtual Event Series 2025

Drug Discovery & Development Virtual Event Series 2024
February 21, 2024 5:30 am Pacific Time

Drug Discovery & Development Virtual Event Series 2024

Drug Discovery & Development Virtual Event Series 2023
February 22, 2023 5:30 am Pacific Time

Drug Discovery & Development Virtual Event Series 2023

Drug Discovery & Development Virtual Event Series 2021
February 24, 2021 5:30 am Pacific Time

Drug Discovery & Development Virtual Event Series 2021

Drug Discovery & Development Virtual Event Series 2020
February 26, 2020 6:00 am Pacific Time

Drug Discovery & Development Virtual Event Series 2020

Drug Discovery Virtual Event Series 2019
February 27, 2019 6:00 am Pacific Time

Drug Discovery Virtual Event Series 2019

Drug Discovery Virtual Event Series 2018
February 21, 2018 6:00 am Pacific Time

Drug Discovery Virtual Event Series 2018

Help

Demographics

Loading Comments...